Business Context and Reporting Period
Company: Stepan Company
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and nine months ended September 30, 2010
Business Overview: Stepan produces intermediate chemicals for consumer and industrial applications across three segments: Surfactants (74% of sales), Polymers (23%), and Specialty Products (3%). The company operates globally with manufacturing sites in North America, Europe, Latin America, and Asia.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Sep 30, 2010 | 9 Months Ended Sep 30, 2010 |
|---|---|---|
| Net Sales | $366,800 | $1,070,334 |
| Gross Profit | $58,429 | $185,459 |
| Operating Income | $31,141 | $94,568 |
| Net Income (Attributable to Stepan) | $19,230 | $56,936 |
| Diluted EPS | $1.73 | $5.14 |
| Cash and Cash Equivalents | $110,965 | $110,965 (Ending Balance) |
| Total Debt | $177,504 | $177,504 (Ending Balance) |
| Operating Cash Flow (9 Months) | N/A | $46,185 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 12% ($40.6M) in Q3 and 11% ($104.8M) for the nine months compared to 2009. Growth was driven by higher average selling prices (passing through raw material costs) and increased sales volumes (4% in Q3, 6% YTD).
- Profitability Pressure: Despite revenue growth, Q3 operating income declined 7% ($2.5M) and gross profit fell 15% ($10.5M) due to rising raw material costs that outpaced price increases. A one-month labor lockout at the Millsdale, Illinois site also impacted margins.
- Expense Reduction: Operating expenses decreased 23% in Q3, primarily due to a $6.7M swing in deferred compensation expense (from expense to income) and reduced legal/environmental costs.
- Acquisitions: The company completed three significant transactions in Q3:
- Purchased manufacturing assets in Singapore ($10.4M) for methyl esters production.
- Acquired Alfa Systems in Poland ($11.8M) to expand polymer capabilities in Eastern Europe.
- Increased ownership in Stepan Philippines Inc. (SPI) from 50% to 88.8%, consolidating the joint venture.
- Debt Increase: Total debt rose to $177.5M from $104.1M at year-end 2009, driven by a new $40M private placement loan and financing for acquisitions.
Guidance, Outlook, and Risks
- Outlook: Management anticipates achieving record full-year earnings despite margin pressure in Europe. Q4 is expected to benefit from the resolution of the Q3 labor dispute and announced price increases to recover margins.
- Growth Drivers: Future volume growth is expected from surfactant expansion in Brazil, polyol expansion in Germany, and the Poland acquisition.
- Capital Expenditures: Full-year 2010 CapEx is estimated at $75M–$80M.
- Risks and Contingencies:
- Environmental/Legal: Accrued liability for environmental and legal losses is $15.9M, with a possible loss range of $6.8M to $31.3M. Key sites include Maywood (NJ), Lightman Drum (NJ), and the newly acquired Poland site.
- Raw Materials: Costs are heavily influenced by crude oil-derived commodities; the company faces competitive pressure in passing these costs to customers.
- Foreign Currency: Fluctuations in exchange rates impacted sales and gross profit comparisons.
Investor Verification Checklist
- Margin Recovery: Verify the effectiveness of Q4 price increases in offsetting raw material cost inflation.
- Acquisition Integration: Monitor the operational ramp-up of the Singapore methyl esters plant (targeted Q1 2012) and the Poland polymer facility.
- Debt Covenants: Confirm continued compliance with debt covenants, specifically the interest coverage ratio (min 2.0:1) and net worth requirements ($175M), given the increased debt load.
- Environmental Reserves: Track updates on the Maywood and Lightman Drum remediation costs, as final costs may differ from current estimates.
- Working Capital: Assess the sustainability of working capital requirements, which consumed $42.2M in the first nine months of 2010 compared to a source of funds in 2009.